Overview Financials News + Filings Key Docs Charts Ownership Insiders
|
|
Crinetics Pharmaceuticals, Inc. (CRNX)
|
|
| Common Size Income Statement |
|
|
|
|
Annual | Quarterly | TTM |
|
| In millions, except per share items | Dec-31-22 | Dec-05-22 | Dec-31-21 | Dec-05-21 | Dec-31-20 | Dec-31-19 | Dec-31-18 | Dec-31-17 |
| | 10-K | 8-K | 10-K | 8-K | 10-K | 10-K | 10-K | 10-K |
| Revenues | | 100.0% | | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% |
| Cost of goods sold | | 127.9% | | 127.5% | 0.0% | 0.0% | 0.0% | 0.0% |
| Gross profit | | -27.9% | | -27.5% | 100.0% | 100.0% | 100.0% | 100.0% |
| Selling, general and administrative | | | | | 105667.6% | 4612.3% | | |
| Research and development | | | | | | | 1008.2% | 451.5% |
| General and administrative | | 31.4% | | 28.7% | | | 274.3% | 94.8% |
| Depreciation | | | | | 1335.2% | 74.4% | 19.4% | 6.3% |
| EBIT | | -124.4% | | -126.2% | -103984.5% | -4226.8% | -1182.5% | -446.3% |
| Pre-tax income | | 0.0% | | 0.0% | -103960.6% | -4226.5% | -1116.8% | -447.8% |
| Income taxes | | 0.0% | | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| Net income | | 0.0% | | 0.0% | -103960.6% | -4226.5% | -1116.8% | -447.8% |
|